Evidence map›Paper›PMID 38822290›Full record

ArticleJournal of nanobiotechnology2024

Retraction Note: Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade.

Sijie Wang, Na Yin, Yongjuan Li, Tingting Xiang, Wenxiao Jiang, Xiu Zhao, Wei Liu, Zhenzhong Zhang, Jinjin Shi, Kaixiang Zhang and 3 more

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Sijie WangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Na YinSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Yongjuan LiAcademy of Medical Sciences, Zhengzhou University, Zhengzhou, 450052, China.
Tingting XiangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Wenxiao JiangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Xiu ZhaoSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Wei LiuSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Zhenzhong ZhangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Jinjin ShiSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Kaixiang ZhangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Xingming GuoCollege of Bioengineering, Chongqing University, Chongqing, People's Republic of China. guoxm@cqu.edu.cn.
Pilei SiDepartment of Breast Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan, 450003, China.
Junjie LiuSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38822290
PMCPMC11140956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.